Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH CONTRACEPTIVE DEVELOPMENT INITIATIVE PLANNED FOR FY 1986

Executive Summary

NIH CONTRACEPTIVE DEVELOPMENT INITIATIVE PLANNED FOR FY 1986 would be funded at $3.35 mil., National Institute of Child Health and Human Development Acting Director Duane Alexander told a March 27 hearing before the House Commerce/Health Subcmte. The initiative would "take advantage of some of the discoveries that are coming in from our basic reproductive sciences research programs that hold great promise for new types of contraception that will be applicable to different segments and ages of the population," Alexander said. NIH contraceptive development grant funding increased from $5.05 mil. in FY 1984 to $7.7 mil. in FY 1985, Alexander said, while funding for contraceptive evaluation increased from $2.5 mil in FY 1984 to $3.45 mil. in FY 1985. Subcmte. Chairman Waxman (D-Calif.) convened the hearing to receive testimony on reauthorization of the Public Health Service Act Title X family planning service program. In FY 1984, NIH "planned to spend over $11 mil." on contraceptive research, "but ended up spending almost 40% less than that," Waxman asserted. This was the "same year" that the congressional Office of Technology Assessment recommended that the agency spend "an additional $20 mil. on contraceptive development," he added.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS008174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel